France Coronary Artery Bypass Graft Market Size, Share, By Method (Off-Pump, On-Pump, Minimally Invasive Direct, and Others), By Surgical Procedure (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery, and Others), By End Use (Hospitals and Cardiology Centers), and France Coronary Artery Bypass Graft Market Insights, Industry Trend, Forecasts to 2035

• France Coronary Artery Bypass Graft Market Size 2024: USD 499.8 Mn
• France Coronary Artery Bypass Graft Market Size 2035:  USD 720.1 Mn
• France Coronary Artery Bypass Graft Market CAGR 2024: 3.58%
• France Coronary Artery Bypass Graft Market Segments: Method, Surgical Procedure, and End Use

The France Coronary Artery Bypass Graft Market Size Refers to the Healthcare and Medical Device Landscape Associated with Surgical Procedures used to Restore Blood Flow to the Heart by Bypassing Blocked or Narrowed Coronary rteries. This market includes surgical techniques, graft materials (such as saphenous vein, internal mammary artery, and radial artery), medical devices, and related services utilized in CABG procedures. In France, the CABG market is driven by the high prevalence of cardiovascular diseases, an aging population, advanced hospital infrastructure, and the presence of skilled cardiac surgeons, with demand primarily focused in public and private hospitals and specialized cardiac care centers.

The Coronary Artery Bypass Graft Market Size in France has been largely influenced by the country's prevalence of cardiovascular diseases and its aging population. Cardiovascular diseases remain a major cause of death in France, with about 140,000 deaths occurring each year. In addition, more than 20% of the population is 65 years old or over, which is a demographic most vulnerable to coronary artery disease. A multitude of people are affected by ischemic heart disease, diabetes, hypertension, and obesity, which therefore necessitates a continuous demand for surgical revascularization procedures. Even though there have been some minimally invasive cardiology advancements, CABG is still a decisive treatment option for cases of severe and multi-vessel coronary artery disease.

The France Coronary Artery Bypass Graft Market Size is positive about demands and opportunities, as it is supported by modern hospital infrastructure, proficient cardiac surgeons, and the government being a strong supporter of cardiovascular research and care. The government, through France 2030 and the national health innovation programs, has planned and spent more than €7.5 billion on healthcare innovation, leading to cardiovascular research, medical devices, and surgical technologies being some of the areas that will benefit from this funding. The funds will be distributed through Inserm, university hospitals, and public-private partnerships. The support of reimbursement from the public healthcare system for coronary artery bypass graft adoption will ensure that there will be sustained demand as well as technological advancement in the France coronary market.

Market Dynamics of the France Coronary Artery Bypass Graft Market:

The France Coronary Artery Bypass Graft Market Size is driven by various factors, including the high incidence of coronary artery disease, an aging demographic with more than 20% of the population being 65 years old and above, and common cardiovascular risk factors such as hypertension, diabetes, and obesity. The demand for CABG operations in France is being additionally lifted by a well-developed public healthcare system, modern hospital facilities, experienced cardiac surgeons, and the continuous perfection of surgical methods and graft materials.

The France Coronary Artery Bypass Graft Market Size is restrained by the rising inclination towards less invasive methods like percutaneous coronary intervention (PCI). The surgical expenses, longer recovery periods, and the risks associated with the postoperative condition hamper the acceptance of the procedure by patients, particularly among the aging population. Moreover, the growth of the market is constrained due to the imposition of stringent regulations and the limited availability of cardiac surgery in certain hospitals.

The France Coronary Artery Bypass Graft Market Size has promising opportunities in the future with the use of minimally invasive and hybrid CABG procedures. The progress of robotic-assisted surgery, better graft materials, and improved perioperative care are all contributing to better clinical outcomes. Ongoing hospital modernization and integrated cardiac care pathways will be instrumental in the market's long-term growth.

Market Segmentation

The France Coronary Artery Bypass Graft Market share is classified into method, surgical procedure, and end use

By Method:

The France Coronary Artery Bypass Graft Market Size is divided by method into off-pump, on-pump, minimally invasive direct, and others. Among these, the on-pump segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The on-pump segment dominates because of its wide clinical acceptance and suitability for complex and multi-vessel coronary disease. It offers better surgical control, stable operating conditions, and proven long-term outcomes. Strong hospital infrastructure and surgeon expertise further support its dominance.

By Surgical Procedure:

The France Coronary Artery Bypass Graft Market Size is divided by surgical procedure into single CABG surgery, double CABG surgery, triple CABG surgery, quadruple CABG surgery, and others. Among these, the triple CABG surgery segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The triple CABG surgery segment growth is due to the high incidence of three-vessel coronary artery disease among France’s aging population. It is a standard and effective treatment for complex coronary blockages. Proven clinical outcomes and strong surgical expertise further support its growth.

By End Use:

The France Coronary Artery Bypass Graft Market Size is divided by end use into hospitals and cardiology centers. Among these, the hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The hospital's segmental growth is due to advanced surgical infrastructure, availability of ICUs, and specialized cardiac surgery teams. Hospitals manage complex and emergency CABG procedures efficiently. Strong public healthcare funding further supports their growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the France Coronary Artery Bypass Graft Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in France Coronary Artery Bypass Graft Market:

• Medtronic plc
• Getinge AB (Maquet)
• Terumo Corporation
• Edwards Lifesciences Corporation
• LivaNova PLC
• Boston Scientific Corporation
• Abbott Laboratories
• B. Braun Melsungen AG
• Teleflex Incorporated
• Karl Storz SE & Co. KG
• Genesee BioMedical
• Cook Medical
• Others

Recent Developments in France Coronary Artery Bypass Graft Market:

• In July 2025, Xeltis announced the launch of Xabg, a novel biorestorative polymeric vascular conduit for CABG, developed to gradually be replaced by native tissue and potentially improve long-term graft patency. Early clinical results in the EU have shown positive safety and flow performance in multi-vessel coronary disease patients

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the France coronary artery bypass graft market based on the below-mentioned segments:

France Coronary Artery Bypass Graft Market, By Method

• Off-Pump
• On-Pump
• Minimally Invasive Direct
• Others

France Coronary Artery Bypass Graft Market, By Surgical Procedure

• Single CABG Surgery
• Double CABG Surgery
• Triple CABG Surgery
• Quadruple CABG Surgery
• Others

France Coronary Artery Bypass Graft Market, By End Use

• Hospitals
• Cardiology Centers